Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Elio Ríboli

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6795-6080; OpenAlex author ID A5067228080. Sources: OpenAlex.

Their work

Papers
36 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
66
Papers, trials and grants by year

2011: 2 papers · 2012: 5 papers · 2013: 6 papers · 2014: 5 papers · 2015: 1 paper · 2016: 3 papers · 2017: 2 papers · 2018: 3 papers · 2019: 2 papers · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 36

  1. Adherence to the Mediterranean diet and risk of pancreatic cancer: an analysis of 2.3 million participants in the Pooling Project of Prospective Studies of Die… Co-author DOI 10.1007/s10654-026-01418-x↗
  2. Prospective Associations of Body Composition and Body Shape With the Risk of Developing Pancreatic Cancer in the UK Biobank Cohort. Last author DOI 10.1002/cam4.70809↗
  3. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Co-author DOI 10.1158/1055-9965.epi-23-0453↗
  4. Plasma concentrations of persistent organic pollutants and pancreatic cancer risk. Co-author DOI 10.1093/ije/dyab115↗
  5. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Co-author DOI 10.1158/0008-5472.can-20-3267↗
  6. Consumption of nuts and seeds and pancreatic ductal adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition. Co-author DOI 10.1002/ijc.32415↗
  7. Healthy lifestyle and the risk of pancreatic cancer in the EPIC study. Co-author DOI 10.1007/s10654-019-00559-6↗
  8. Methodological issues in a prospective study on plasma concentrations of persistent organic pollutants and pancreatic cancer risk within the EPIC cohort. Co-author DOI 10.1016/j.envres.2018.11.027↗
  9. Socioeconomic Effect of Education on Pancreatic Cancer Risk in Western Europe: An Update on the EPIC Cohorts Study. Co-author DOI 10.1158/1055-9965.epi-18-1153↗
  10. Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations. Co-author DOI 10.1002/ijc.31146↗
  11. Lifetime and baseline alcohol intakes and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition study. Co-author DOI 10.1002/ijc.31367↗
  12. Circulating plasma phospholipid fatty acids and risk of pancreatic cancer in a large European cohort. Co-author DOI 10.1002/ijc.31797↗
  13. Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition… Co-author DOI 10.1002/ijc.30590↗
  14. Mediterranean diet and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition cohort. Co-author DOI 10.1038/bjc.2017.14↗
  15. Flavonoid and lignan intake and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort. Co-author DOI 10.1002/ijc.30190↗
  16. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Co-author DOI 10.18632/oncotarget.11041↗
  17. Sweet-beverage consumption and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Co-author DOI 10.3945/ajcn.116.130963↗
  18. Plasma carotenoids, vitamin C, retinol and tocopherols levels and pancreatic cancer risk within the European Prospective Investigation into Cancer and Nutritio… Co-author DOI 10.1002/ijc.29175↗
  19. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/ng.3052↗
  20. Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS d… Co-author DOI 10.1093/carcin/bgu010↗
  21. Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Co-author DOI 10.1136/gutjnl-2012-303477↗
  22. Genes-environment interactions in obesity- and diabetes-associated pancreatic cancer: a GWAS data analysis. Co-author DOI 10.1158/1055-9965.epi-13-0437-t↗
  23. Leukocyte telomere length in relation to pancreatic cancer risk: a prospective study. Co-author DOI 10.1158/1055-9965.epi-14-0247↗
  24. Meat and fish consumption and risk of pancreatic cancer: results from the European Prospective Investigation into Cancer and Nutrition. Co-author DOI 10.1002/ijc.27637↗
  25. Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and… Co-author DOI 10.1002/ijc.27875↗
  26. Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Co-author DOI 10.1007/s10552-012-0138-0↗
  27. Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European Prospective Investigation into Nutrition a… Co-author DOI 10.1016/j.cgh.2013.05.029↗
  28. Dietary intake of acrylamide and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Co-author DOI 10.1093/annonc/mdt255↗
  29. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Last author DOI 10.1136/gutjnl-2012-303006↗
  30. The association of circulating adiponectin levels with pancreatic cancer risk: a study within the prospective EPIC cohort. Co-author DOI 10.1002/ijc.26244↗
  31. Plasma cotinine levels and pancreatic cancer in the EPIC cohort study. Co-author DOI 10.1002/ijc.26452↗
  32. Dietary intake of iron, heme-iron and magnesium and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort. Co-author DOI 10.1002/ijc.27547↗
  33. Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Co-author DOI 10.1038/bjc.2012.19↗
  34. Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Co-author DOI 10.1093/carcin/bgs151↗
  35. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into … Co-author DOI 10.1007/s00125-011-2316-0↗
  36. A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Co-author DOI 10.1016/j.ejca.2011.02.007↗

Closest collaborators

The 25 strongest of 66 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eric J. Duell · 24 shared papers, 2011–2020 · strength 0.79
  2. Malin Sund · 21 shared papers, 2011–2020 · strength 0.66
  3. H. Bas Bueno-de-Mesquita · 20 shared papers, 2011–2020 · strength 0.62
  4. Verena Andrea Katzke · 12 shared papers, 2013–2020 · strength 0.53
  5. Rudolf Kaaks · 15 shared papers, 2011–2020 · strength 0.46
  6. Guri Skeie · 12 shared papers, 2011–2020 · strength 0.43
  7. Weimin Ye · 16 shared papers, 2011–2018 · strength 0.41
  8. Konstantinos K. Tsilidis · 2 shared papers, 2017–2025 · strength 0.41
  9. Esther Molina‐Montes · 16 shared papers, 2011–2017 · strength 0.39
  10. Sofia Christakoudi · 1 shared paper, 2025 · strength 0.37
  11. Vinciane Rebours · 6 shared papers, 2017–2020 · strength 0.34
  12. Paolo Vineis · 13 shared papers, 2011–2018 · strength 0.30
  13. Sabine Naudin · 4 shared papers, 2018–2020 · strength 0.25
  14. Dagfinn Aune · 4 shared papers, 2017–2020 · strength 0.24
  15. Dominique S. Michaud · 10 shared papers, 2011–2016 · strength 0.21
  16. Bas H. Bueno-de-Mesquita · 4 shared papers, 2011–2020 · strength 0.16
  17. Pietro Ferrari · 4 shared papers, 2013–2020 · strength 0.16
  18. Verena A. Grote · 7 shared papers, 2011–2015 · strength 0.15
  19. Suzanne M. Jeurnink · 7 shared papers, 2011–2015 · strength 0.14
  20. Leila Luján‐Barroso · 4 shared papers, 2012–2020 · strength 0.13
  21. Mireia Obón‐Santacana · 3 shared papers, 2013–2020 · strength 0.13
  22. Paul Brennan · 2 shared papers, 2018–2020 · strength 0.12
  23. Peter Derk Siersema · 5 shared papers, 2012–2015 · strength 0.11
  24. María‐Dolores Chirlaque · 3 shared papers, 2012–2018 · strength 0.11
  25. Charlotta Rylander · 2 shared papers, 2016–2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.